This is a promotional website intended for UK healthcare professionals (HCPs) only. Adverse event reporting can be found at the bottom of the page.
You have no items in your basket.
Encepur® – Tick-borne Encephalitis Vaccine, inactivated
Encepur® is an inactivated vaccine developed for active immunisation against tick-borne encephalitis (TBE). This serious viral infection, transmitted by ticks, can lead to neurological complications such as meningitis and encephalitis.
Encepur® is an inactivated vaccine that protects against tick-borne encephalitis (TBE), a viral infection transmitted through tick bites. TBE can cause serious illness, including inflammation of the brain and nervous system.
Encepur® is used for the active immunisation against tick-borne encephalitis (TBE), a viral infection spread by tick bites.
It is intended for:
Residents in endemic regions where TBE is common
Travellers to affected areas, especially during spring and summer months
Outdoor workers and nature enthusiasts frequently exposed to ticks
Children and adults who need reliable protection from TBE-related neurological complications
There is no linked vaccine with the product, please select the appropriate vaccine in the product settings.
Find out more
01 September 2025
Encepur® is indicated for the prevention of tick-borne encephalitis (TBE) and should be administered in accordance with official vaccination guidelines. The vaccine is suitable for both adults and children, with schedules tailored to specific age groups and risk levels.Please consult the Summary of Product Characteristics (SmPC) and Patient Information Leaflet for complete prescribing information, contraindications, and possible side effects. For medical advice, speak to your healthcare provider.
Report adverse section with red color background option, enable/disable CTA
Footer sticky/non sticky
Gain full access to all of our content by creating an account.